Chi-Med Announces Amendment to the 2013 License & Collaboration Agreement on Fruquintinib with Eli Lilly and Company Dec 20, 2018 Life Science
AC Immune and WuXi Biologics to Establish an Exclusive Strategic Partnership Dec 19, 2018 Life Science
Mobidiag Announces Joint Venture with Autobio Diagnostics and €10m Equity Investment Dec 19, 2018 Life Science
Lee’s Pharm Enters $22.5 Million Deal for AI-Discovered Preclinical Molecule Dec 19, 2018 Life Science
Junshi Biosciences’s Tuoyi is First China-Developed Anti-PD-1 Drug Approved for Marketing Dec 19, 2018 Life Science
Roxadustat approved in China for the treatment of anaemia in chronic kidney disease patients on dialysis Dec 18, 2018 Life Science
Innovent Biologics and Incyte Announce Strategic Collaboration and Licensing Agreement for Three Clinical-stage Product Candidates in China Dec 17, 2018 Life Science
Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial Dec 17, 2018 Life Science
Cerveau Technologies, Inc. to Support a First Clinical Study in Asia of a Novel Biomarker of Alzheimer’s Disease Dec 14, 2018 Life Science
Wuxi AppTec, Juno Therapeutics Hope to Release CAR-T Cancer Treatment by 2020 Dec 14, 2018 Life Science
Innovent Sees Positive Data from China Phase III Trial of Avastin Biosimilar Dec 14, 2018 Life Science
WuXi Biologics Congratulates Tychan on First-in-Class Monoclonal Antibody for Yellow Fever after Record 7 Months of Development Dec 13, 2018 Life Science